Drug profile · INN
elvitegravir/cobicistat/ emtricitabine/tenofovir alafenamide fumarate
GENVOYA
elvitegravir/cobicistat/ emtricitabine/tenofovir alafenamide fumarate (GENVOYA) is an FDA-listed pharmaceutical active ingredient.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — elvitegravir/cobicistat/ emtricitabine/tenofovir alafenamide fumarate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
elvitegravir/cobicistat/ emtricitabine/tenofovir alafenamide fumarate (GENVOYA) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN elvitegravir/cobicistat/ emtricitabine/tenofovir alafenamide fumarate
Brand GENVOYA
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Frequently asked questions
What is elvitegravir/cobicistat/ emtricitabine/tenofovir alafenamide fumarate?
elvitegravir/cobicistat/ emtricitabine/tenofovir alafenamide fumarate (GENVOYA) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for elvitegravir/cobicistat/ emtricitabine/tenofovir alafenamide fumarate?
GENVOYA is a marketed brand name for elvitegravir/cobicistat/ emtricitabine/tenofovir alafenamide fumarate. Check FDA Drugs@FDA for the current US label holder and prescribing information.